Combination approach reduces spread of drug-related HIV

March 4, 2014

A computer model has created the most effective formula for reducing the spread of HIV among drug users in New York City over the next 25 years. Developed by scientists at Columbia University's Mailman School of Public Health and Brown University, the model recommends a combination of interventions, including increased HIV testing, improved access to substance abuse treatment, increased use of needle and syringe exchange programs, and broad implementation of antiretroviral treatment as prevention. The result would lower new infections by more than 60% by 2040.

Results are published online in the March issue of the journal Health Affairs, which includes a cluster of articles on HIV/AIDS in America.

To estimate the effectiveness of various prevention settings, the researchers modeled HIV transmission in a group of sexually active adults age 15 to 64 in the New York metropolitan area, including those who inject drugs, who are non–injection , and people who do not use drugs. They compared the projected HIV incidence in 2020 and 2040 using current approaches to the incidence if one or more of the four interventions were applied.

The combination of all four approaches led to the largest proportion of news cases averted. Scaling-up all four interventions simultaneously resulted in a 62.4% decrease in new infections by 2040.

"A combination intervention of scaling up - as-prevention strategies by increasing access to HIV treatment for people who inject drugs, improving their adherence to therapy, and ensuring that they remained in care was the most effective approach that we analyzed," said Sandro Galea, MD, DrPH, Gelman Professor and chair of the Department of Epidemiology at the Mailman School of Public Health.

Every hypothetical strategy on its own resulted in a greater reduction in HIV compared to the strategies that are in place now. Increased HIV testing resulted in a 12% percent reduction; with expanded access to there was a 26% reduction. The other reductions were 34% for increased and syringe program usage, and 45% percent for scaling up treatment as prevention.

When two of the four interventions were combined—improving needle exchange programs and scaling up HIV treatment and care—the gains produced almost as much reduction in new HIV cases as all four interventions together. No strategy completely eliminated HIV transmission.

"This modeling demonstrates that there is an important role to play for the whole spectrum of prevention efforts we have at our disposal," said Brandon Marshall, PhD, assistant professor of at Brown and a former postdoctoral scholar at the Mailman School. "Importantly, this research supports the goals of New York's Enhanced Comprehensive Prevention Plan that calls for increased HIV testing, programs to improve retention in HIV care, syringe exchange funding, and better linkage to substance for people who use drugs. We really have to redouble our efforts scaling up these programs if we are to achieve the objectives of this ambitious plan, and ultimately, get incidence down to zero."

Recent surveillance data from the Centers for Disease Control and Prevention indicate that approximately one in ten new HIV infections annually—or 4,000 cases—are attributable to the injection of drugs. Drs. Galea and Marshall suggest that their latest results might also have important implications for international settings especially those that restrict or prohibit access to harm reduction programs.

Also of note, according to Dr. Marshall: "While this particular study did not focus on the cost effectiveness aspect, other research has showed that the interventions we modeled turn out to be cost-saving—on an average of $350,000 in lifetime treatment costs—because they prevent new infections."

Explore further: Predicting success of HIV interventions in NYC

Related Stories

Predicting success of HIV interventions in NYC

March 4, 2014
New York City continues to battle an HIV epidemic, including among drug users. There are many possible interventions. Researchers have developed a sophisticated predictive computer model to help policymakers figure out which ...

Reducing HIV transmission among drug injectors lowers AIDS mortality in heterosexuals

February 21, 2014
Although community network studies show that sexual relationships occur between members of "risk groups"—men who have sex with other men (MSM), people who inject drugs (PWID), non-injection drug users (NIDU)—and heterosexuals, ...

The importance of treating pediatric AIDS in the elimination agenda

August 27, 2013
Scott Kellerman and colleagues argue that the scope of the current HIV elimination agenda must be broadened in order to ensure access to care and treatment for all children living with HIV.

How ACA affects vulnerable Americans living with HIV/AIDS

March 3, 2014
A series of papers in the March issue of Health Affairs examines how the Affordable Care Act could affect two sectors of the most vulnerable Americans—those living with HIV/AIDS and people who have recently cycled through ...

Proportion of opioid treatment programs offering on-site testing for HIV and STIs declines

December 24, 2013
A survey of opioid treatment programs finds that the proportion offering on-site testing for human immunodeficiency virus (HIV) and sexually transmitted infections (STIs) declined substantially between 2000 and 2011, despite ...

Risk of HIV infection is high during pregnancy and the postpartum period

February 25, 2014
Women living in world regions where HIV infection is common are at high risk of acquiring HIV infection during pregnancy and the postpartum period, according to a study by US researchers published in this week's PLOS Medicine. ...

Recommended for you

Scientists divulge latest in HIV prevention

July 25, 2017
A far cry from the 1990s "ABC" campaign promoting abstinence and monogamy as HIV protection, scientists reported on new approaches Tuesday allowing people to have all the safe sex they want.

Girl's HIV infection seems under control without AIDS drugs

July 24, 2017
A South African girl born with the AIDS virus has kept her infection suppressed for more than eight years after stopping anti-HIV medicines—more evidence that early treatment can occasionally cause a long remission that, ...

Meds by monthly injection might revolutionize HIV care (Update)

July 24, 2017
Getting a shot of medication to control HIV every month or two instead of having to take pills every day could transform the way the virus is kept at bay.

Candidate AIDS vaccine passes early test

July 24, 2017
The three-decade-old quest for an AIDS vaccine received a shot of hope Monday when developers announced that a prototype triggered the immune system in an early phase of human trials.

Paris spotlight on latest in AIDS science

July 21, 2017
Some 6,000 HIV experts gather in Paris from Sunday to report advances in AIDS science as fading hopes of finding a cure push research into new fields.

Scientists elicit broadly neutralizing antibodies to HIV in calves

July 20, 2017
Scientists supported by the National Institutes of Health have achieved a significant step forward, eliciting broadly neutralizing antibodies (bNAbs) to HIV by immunizing calves. The findings offer insights for HIV vaccine ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.